معرفی
Afzal Syed is a Researcher holding a shared position at the DKFZ Single Cell Open Lab and affiliated with BIOQUANT (Center for Molecular Biology) at Heidelberg University. He earned his PhD from the University of Basel, Switzerland, where he investigated microRNAs and splicing factors in cell identity establishment and maintenance.
His research spans single-cell multi-omics methodology development and application to hematological malignancies, with intense focus on molecular epigenetic deregulation and resistance mechanisms in acute myeloid leukemia subtypes. Previous work at Helmholtz Zentrum Munich involved high-throughput CRISPR-Cas9 screening to dissect transcriptional regulation of nuclear hormones and characterize non-coding RNA functions. Core expertise includes genomic technologies, epigenetic mechanisms, and cancer biology with specialization in hematological cancers.
Dr. Syed operates within the Chromatin Networks research group framework at BIOQUANT and conducts experimental work at the DKFZ Single Cell Open Lab facility, leveraging institutional resources for translational cancer research.
